Who is the CEO of Epsilon Healthcare Limited?

The CEO of Epsilon Healthcare Limited is Daniel Sanghera.

What industry does Epsilon Healthcare Limited belong to?

Epsilon Healthcare Limited operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.

Where is Epsilon Healthcare Limited headquartered?

Epsilon Healthcare Limited is headquartered at 9 Castlereagh Street, Sydney, NSW, 2000, AU.

What is the IPO date of Epsilon Healthcare Limited?

Epsilon Healthcare Limited went public on May 4, 2017.

How many employees does Epsilon Healthcare Limited have?

The total number of employees at Epsilon Healthcare Limited is disclosed periodically in the company's annual financial reports.

Epsilon Healthcare Limited

EPN.AX•ASX

Healthcare

Drug Manufacturers - Specialty & Generic

A$0.02

A$0.00(0.00%)

Epsilon Healthcare Limited (EPN.AX) Company Profile & Overview

Explore Epsilon Healthcare Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Epsilon Healthcare Limited (EPN.AX) Company Profile & Overview

Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia.

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

CEODaniel Sanghera

Contact Information

https://epsilonhealthcare.com.au

9 Castlereagh Street, Sydney, NSW, 2000

Company Facts

IPO DateMay 4, 2017

CountryAU

Frequently Asked Questions

;